chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a little bit of tachycardia you know like heart rate little bit like 100 & 102 for about like 3 hours; This is a spontaneous report from a contactable consumer reported for herself. A 45-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection Batch/Lot Number: EL9269) via an unspecified route of administration on 12Feb2021 as dose number unknown, single at the age of 45-years-old for COVID-19 immunization.Medical history included headache and migraine. Concomitant medications included galcanezumab gnlm (EMGALITY [GALCANEZUMAB GNLM]) monthly taken for headache and migraine.On 12Feb2021, she experienced tachycardia 10 to 15 minutes ago, that lasted for 3 to 4 hours and wanted to know if she should get the second dose of vaccine and if there was any listed drug interactions listed when taking the vaccine. Patient reported that she had a little bit of tachycardia you know like heart rate little bit like 100 & 102 for about like 3 hours and asked if this is that normal. No treatment was received for event. The patient did take a drug Emgality, which was monoclonal antibodies injections that prevent taking once in month you know for prevention of headache or migraine. Reporter asked is there any interaction between this and vaccine because she have to take it like be safe. The patient underwent lab tests which included Complete Blood Count resulted as regular checkup labs nothing on an unspecified date and heart rate resulted as 100 & 102 on 12Feb2021. The patient recovered from event on unspecified date in 2021.  No Follow-up attempts are possible. Information about lot/batch cannot be obtained.
Fever (100.2), swelling, redness, warm to touch at injection site, vomiting, nausea, diarrhea, and weakness.
Pain at injection site; Small shingles/ possible shingles; Blister; feels nerve pain on his face; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th November 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 5th December 2022, 6 days after receiving Shingrix, the patient experienced injection site pain, shingles, blister and facial neuralgia. On an unknown date, the outcome of the injection site pain, shingles and facial neuralgia were not recovered/not resolved and the outcome of the blister was unknown.   It was unknown if the reporter considered the injection site pain, shingles, blister and facial neuralgia to be related to Shingrix.     Additional Information: GSK receipt date: 05-DEC-2022 Reporters comment: The pharmacist reporting a possible case of shingles in a patient who received their Shingrix vaccine in the left arm at her pharmacy and experienced pain at the injection site and what appeared to be small shingles like blisters on the left arm that appeared this morning (reporting day) and also feels nerve pain on his face. The patient was also a doctor, he would go to his health care professional for further evaluation. The reporter consent to follow-up.
Pt received Pfizer vaccines on 03/01/2021 and 03/22/2021. Pt was brought to the ED by her husband with complaints of AMS on 11/18/21. Pt was noted to not be eating or drinking as usual. Pt was found to be COVID positive. Pt was not hypoxic and was not a candidate for Remdesivir. Pt discharged on 11/26 with home care.
This is a spontaneous report from a contactable consumer. A 83 years old female patient received single dose of PREVNAR 13 on 06Nov2014. The patient received PREVNAR 13 because of her age and as she had a history of pneumonia. Other medical history included some surgeries for back problem and allergies twice a month. Past vaccine history included PNEUMOVAX on unspecified date. Concomitant medications included diltiazem (unknown manufacturer) at 240 mg, 1x/day, DIOVAN at 320 mg, 1x/day, warfarin (unknown manufacturer) at 15 mg, weekly, LEVOXYL at 100 ug, 1x/day, SINGULAIR at 10 mg, 1x/day, LIPITOR at 40 mg, 1x/day. The consumer had no reaction to vaccination until 11Nov2014. On that day the consumer had as delayed reaction some arm pain at the injection site. In the morning of 14Nov2014 the arm on where she had injection was all reddened on the two large areas, her arm was quite red and hot/arm was all red and hot. The consumer reported there was something wrong with this batch of PREVNAR 13. The consumer was concerned as she was going for allergies twice a month and she wanted to know whether this was a normal reaction to vaccine or whether there was something wrong with the batch that was administered. The consumer underwent blood work on unspecified date and results were normal. The consumer did not recover from some arm pain at the injection site. Outcome of the other reported events was unknown.
Hospitalized 01/21/2022; COVID-19 positive 01/21/2022; fully vaccinated    Admission Date: 1/21/2022 Discharge Date: 01/29/2022 PRESENTING PROBLEM:  Acute respiratory failure with hypoxia  [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE:   82 y/o male hx of HFrEF with EF 29% s/p ICD, CAD, persistent a fib, who presented with dyspnea. He tested positive for COVID 2 days PTA. Home oxygen was 75% on day of admission. He received original vaccine series in 4/2021 but no booster. Upon arrival he was placed on NRB with improvement in oxygen saturations. He had WBC of 12.84, bicarb 28, BUN 21. CXR showed severe COVID 19. He was started on dexamethasone and admitted for further management. He was also started on remdesivir.  Initially was requiring higher oxygen via high-flow nasal cannula, his steroids were switched to IV Solu-Medrol due to increased oxygen requirement.  Diuresed with IV Lasix, oxygen requirement gradually improved, steroids were eventually switched to prednisone and gradually tapered.  Diabetes management evaluated the patient due to high blood sugars during the hospitalization he was on Lantus with correction scale.  Eventually oxygen requirement improved down to 2 L, evaluated by Pulmonary rehab recommended 2 L oxygen all the time.  Diabetes management recommended NPH 70/30, 24 units 2 times a day along with metformin 1000 mg 2 times a day upon discharge.  Evaluated by PT and OT recommended home care, Care Management arranged for home care, instructions discussed in detail with patient he verbalized understanding, discharge home today in stable condition.
Patient became dizzy and nauseated an hour and a half after administration. Pt states she was sick the previous week but felt well at time of administration. Pt rested after being evaluated. Pt did not have a high pulse or blood pressure at time of event. Pt advised to rest and drink plenty of fluids if not feeling nauseated.
Fever, chills, headache, body aches, severe nausea, dizziness and loss of appetite
congestion; sore throat; allergic reaction to her first dose of Moderna Covid-19 Vaccine; coughing caused by sinus drainage; low grade fever; pounding headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage) and PYREXIA (low grade fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 05-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage), PYREXIA (low grade fever) and HEADACHE (pounding headache). At the time of the report, NASAL CONGESTION (congestion), OROPHARYNGEAL PAIN (sore throat), HYPERSENSITIVITY (allergic reaction to her first dose of Moderna Covid-19 Vaccine), COUGH (coughing caused by sinus drainage), PYREXIA (low grade fever) and HEADACHE (pounding headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant included allergy medication when required. No treatment was reported by the reporter.
Hives on buttocks appearing 11/12/09 at 3 AM. Pt also had been on AUGMENTIN-unclear if hives from vaccine or med.
swollen tongue after the 1st vaccine; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced swollen tongue after the 1st vaccine. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Patient received the vaccine in the Right Arm on Monday. On Tuesday, patient developed a rash on his right arm that spread to his right trunk area.
VACCINE WAS ADMINISTERED ON 2/27/23 AFTER EXPIRATION DATE (2/24/23).
Developed itching chest, ribs 2 days after Flu vaccine 10/22/12 received Hep B #1 and Tdap at 1330 rash increased on torso, fever 98.9 degrees F by 2000 put BENADRYL ointment on itchy areas on 10/23/12 itching is improving.
I have tingling and burning feet more than 10 weeks now; I have tingling and burning feet more than 10 weeks now; feet fatigue; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as DOSE 1, SINGLE for COVID-19 immunization. On an unspecified date, the patient experienced tingling and burning feet more than 10 weeks now, after 2nd shot of pfizer Covid-19 vaccination and feet fatigue. Outcome of the events was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Patient received an adult Pfizer COVID-19 vaccine of 0.2ml intramuscularly instead of pediatric Pfizer vaccine. Error was discovered when reviewing LOT numbers after administering second dose . Patient and primary care physician were contacted about the error. No reported adverse effects by the patient or guardian from the first dose. Vaccination dose series is complete for this patient.
Patient is a 73 year old male with a past medical history significant for Alzheimers dementia, hypertension, hyperlipidemia, BPH, who was brought to the emergency department by his nursing home after having a witnessed seizure. Patient is a poor historian so all information is obtained from patient's wife who got report from the nursing home as to what occurred. Apparently patient was walking with his aide when he began to shake involving his whole body and was lowered to the ground. After the shaking ended, patient was lethargic and 911 was called.
6-10-10 Pt. given PENTACEL, PREVNAR and Hep B (1st series). 8-5-10 Return visit for second series. Mother informed me that after first series child had TYLENOL remained fussy and inconsolable for 24 hrs. at that time pt was deferred for #2 series.
Local injection site redness swelling heat and pain/local site is very painful and still red; Local injection site redness swelling heat and pain; Local injection site redness swelling heat and pain; Local injection site redness swelling heat and pain/local site is very painful; headache; extreme fatigue; diarrhea; This is a spontaneous report from a contactable Nurse (patient). A 39-year-old female patient received the second dose of BNT162b2 (Lot number: EL1284), intramuscular in left arm on 08Jan2021 15:00 at single dose for covid-19 immunization. Medical history included Hemeplegic migraines, wolff-parkinson-white syndrome (wpw), hypertension (htn), known allergies: Penicillin (PCN) and Sulfonamide (sulfa). The patient's concomitant medication was unspecified product. The patient previously received the first dose of BNT162b2 (Lot number: EH9899), at the age of 39-year-old, intramuscular in left arm on 18Dec2020 15:00 at single dose for covid-19 immunization. The patient experienced local injection site redness swelling heat and pain. Also noted was headache, extreme fatigue and diarrhea. But local site is very painful and still red day 3. The events were occurred at 12:00 on 09Jan2021. The patient did not receive the treatment for the events. The patient was not pregnant. The outcome of the events was recovering.
6 days after vaccine I developed painful hives along my joints, many on my hands, swollen lymph nodes, swollen tongue, both affecting swallowing, severe burning sensation on my tongue, numerous sores in my mouth including on my gums, and cold sores on my lips. As a result I?m unable to speak or eat. Recommended treatment has been Tylenol, and antihistamine. I?ve been taking probably more than recommended of both, and as of today, all symptoms persist.
Patient was administered vaccine beyond the use-by time based on the time of removal from storage and withdrawal.  The patient was monitored for 30 minutes following  injection. She reported no adverse reaction on the day of the vaccination and was released to resume normal activities.
Generalized rash on 11/12/02. Given Benadryl by private doctor.
He did things on time and other things not on time while at the same time forgetting things . Noticed since real little 3 months old. Getting help and treatment at Rehab center. 7 months old when noticed alot of not paying attention. he really went backwards at 18 months old. 60 day follow up states pt has not recovered. His eye have a disease in them (one wants to cross). his teeth #3 underbite. His learning is always going to be difficult. is stool unlesson a diet and certain minerals etc is always going to be a problem. He acts up at times and speech. For only having one child things have been up and down. Everybody thought he was a monster at age 2. Dirty looks and jokes at least he doesn't remember that. Things are better now but I sure went through hell for about 3 1/2 years and was extremely stressed out.
Irritation at site of injection (right shoulder): 2- or 3-inch diameter raised area of redness, soreness, tenderness.
Shingles like rash on head/face/eye. Pain. Family doctor prescribed valacyclovir 1gm tid and Hydrocodone/ACAP. Patient referred to ophthalmologist.
Information has been received from a case in litigation via a case report concerning a female who on 29-MAR-1999 was vaccinated with a dose of RECOMBIVAX HB (manufacturer unknown). On 12-APR-1999, a special master said that the patient was seen by a neurologist with complaints of tingling in both legs, numbness and weakness of her left arm and unusual abdominal muscle contractions. The patient said her problems began with her legs around 19-NOV-1998. She reported weakness and burning sensation in both feet and legs. The special master, based on the testimony of the treating physician ruled that existing neurological symptoms when the patient had a 1999 RECOMBIVAX HB (manufacturer unknown) were due to structural spinal injuries from a 1995 accident. That represented a deviation from the patient's original petition, which asserted aggravation, and from the special master's 2006 order to show cause, which found that the patient's neurological condition had gradually deteriorated beginning well before the 29-MAR-1999, administration of the RECOMBIVAX HB (manufacturer unknown). A Vaccine Court special master has reversed her earlier skepticism that the RECOMBIVAX HB (manufacturer unknown) caused the petitioner's transverse myelitis and eventual multiple sclerosis and ruled that compensation should be paid. This is the rare case in which the experts from both sides agreed that the petitioner's medical theory is biologically plausible, a Special Master said "Petitioner has proved a logical sequence of cause and effect, and appropriate temporal interval between vaccination and onset." The special master said the physician testifying for the respondent, said that three days between the vaccination and onset of symptoms was too soon for a demyelinating injury to develop but another physician said that if the petitioner had been "primed" by some earlier exposure, the onset can be faster. Moreover, a special Master said, a neuroimmunologist testified at an omnibus hepatitis b proceeding that he would expect a reaction in humans from three to 30 days after vaccination. Upon internal review, transverse myelitis and multiple sclerosis were found to be other important medical events. No further information is available.
This non-valid, spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No information was provided regarding the patients' medical history, previous drug reactions, allergies, concurrent medical conditions or concomitant medications. On unknown dates, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB lot number N034005 (expiration date 31-JAN-2020) and lot number reported as "N021920" (expiration date 07-FEB-2020) for prophylaxis (doses, routes and anatomical locations of administration were not reported). Additionally, the patients were vaccinated with ROTATEQ by oral route, lot number N005078 (expiration dates 22-NOV-2018 and 04-OCT-2018) for prophylaxis (doses were unknown), GARDASIL 9 lot number N020352 (expiration date 10-APR-2020) for prophylaxis (doses, routes and anatomical locations of administration were not provided) and M-M-R II for prophylaxis (dose numbers, routes and anatomical locations of administration were not provided; lot numbers N010496 [expiration date 31-MAR-2019], N014485 [expiration date 10-MAY-2019], and N023149 [expiration date 24-AUG-2019]). The vaccines were reconstituted with sterile diluent which was reported to be properly stored. The doses of all vaccines were exposed to a temperature excursion below 32 degrees Fahrenheit (F) (also reported as 31F) during a time frame of 15 days, which was detected by the Digital Data Logger. There was no prior temperature excursion and no adverse effects were reported. Follow-up information was received from the nurse on 17-DEC-2018. The reporter provided patients' demographics which made the case valid. This report refers to a 4-year-old patient of unknown gender. On 19-MAY-2018, the patient was vaccinated with an improperly stored dose of VARIVAX lot # N0217202, expiration date 10-AUG-2019 (exact dose and route of administration were not reported) for prophylaxis. This is one of multiple reports received from the same reporter. Sender's Comments: US-009507513-1807USA011661.
June 16th onset of fever and child complaining of pain taken to doctors. June 20th taken to ER for high fever 103.7 and examined. Illness continued. June 22nd appearance of rash on face, back, shoulders, stomach. Child still complaining of pain. Another visit to doctor on June 25th. Child still complaining of occasional pain.
body, joint, shoulders and arms pains; body, joint, shoulders and arms pains; muscle aches; body, joint, shoulders and arms pains; body, joint, shoulders and arms pains; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 74 year-old male patient received bnt162b2 (BNT162B2), administration date 02Nov2021 (Batch/Lot number: unknown) at the age of 73 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), administration date: 2021, for COVID-19 immunization; Covid-19 vaccine (Dose 2, Manufacturer unknown), administration date: 2021, for COVID-19 immunization. The following information was reported: ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious), PAIN (non-serious), ARTHRALGIA (non-serious) all with onset Nov2021, outcome "not recovered" and all described as "body, joint, shoulders and arms pains"; MYALGIA (non-serious) with onset Nov2021, outcome "not recovered", described as "muscle aches". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller stated that early Nov2021, after booster dose, it felt like something attacked his joints and muscle groups, after the booster dose.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Full body burning itch all day on Jan 7 (starting at 930 am, vaccine received at 840 am) and Jan 8. Developed upper body+face rash (noticed around 5 pm) and lower body hives/welts on Jan 8. Airway was not compromised during the whole event. Took Allegra BID, pepcid and singular QHS on Jan 7. Took Allegra and Pepcid BID, singularity QHS, and 50 mg benadryl on Jan 8.  Discussed with immunologist, Dr. on Jan 8 to assess if ER trip required, determined it was not as symptoms mostly calmed by 11 pm/midnight on Jan 8-Jan 9.
INFLAMMATION IN VARIOUS MUSCLES; INFLAMMATION IN  TENDONS; INFLAMMATION IN JOINTS/INFLAMMATION MOVING AREA TO AREA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced inflammation in various muscles, inflammation in tendons, and inflammation in joints/inflammation moving area to area. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from inflammation in various muscles, inflammation in tendons, and inflammation in joints/inflammation moving area to area. This report was non-serious.
Confusion, Headache, Myalgia, Arthralgia, Fever, Chills Narrative:  Johnson and Johnson vaccine - Only upper body body aches and joints, bad headache with light sensitivity, nauseous, feeling a little disoriented - don't feel irrational but just foggy, forgetful--got home and left car running in driveway, fever 99.7, chills; taking Tylenol, but did not at first because she was told to wait at least 12 hours before taking anything.
chills, fatigue Narrative: Patient reports some dizziness, chills, and fatigue. Symptom ongoing.